Amygdala Neurosciences Inc — Form D
Amygdala Neurosciences Inc of San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-04-29. The offering totals $1.4M, of which $1.4M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2015-04-29
- Form: D
- Accession: 0001640814-15-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.4M
- Amount sold: $1.4M
- Investors: 25
- Date of first sale: 2015-04-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-238824
Issuer
- Name: Amygdala Neurosciences Inc
- CIK: 0001640814
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 5214F Diamond Heights Blvd. #151, San Francisco, CA, 94131
- Phone: (650) 714-0553
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Ivan F Diamond | Executive Officer | San Francisco, CA |
| Peter M Strumph | Director | San Francisco, CA |
| Peter M Strumph | Executive Officer | San Francisco, CA |
| Ivan F Diamond | Director | San Francisco, CA |
| Howard F Jaffe | Director | San Francisco, CA |
| Louis G Lange | Director | San Francisco, CA |
| William F Lee | Director | San Francisco, CA |
| Adrienne M MacMillan | Executive Officer | San Francisco, CA |
| Mack C Mitchell, Jr. | Director | San Francisco, CA |
Other filings by this issuer (1)
More